| 60-107 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
100 µg |
|
5 vials/pack |
Refrigerate |
| 60-107.2 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
200 µg |
|
5 vials/pack |
Refrigerate |
| 60-107.21 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
20 µg |
|
5 vials/pack |
Refrigerate |
| 60-107.5 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
500 µg |
|
5 vials/pack |
Refrigerate |
| 60-107A150 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9); in DMSO |
150 µL/vial; 1 mg/mL |
|
5 vials/pack |
Ultra-low (-80°C) |
| 60-157 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
100 µg |
|
1 vial/pack |
Refrigerate |
| 60-157.2 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
2.0 mg |
|
1 vial/pack |
Refrigerate |
| 60-164 |
2-Aminoanthracene (2AA) |
Indirect Acting Mutagen (+S9) |
50 µg |
|
1 vial/pack |
Refrigerate |
